^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    GENE:

    ACAA2 (Acetyl-CoA Acyltransferase 2)

    i
    Other names: ACAA2, Acetyl-CoA Acyltransferase 2, DSAEC, Mitochondrial 3-Oxoacyl-Coenzyme A Thiolase, 3-Ketoacyl-CoA Thiolase, Mitochondrial, Mitochondrial 3-Oxoacyl-CoA Thiolase, Acetyl-Coenzyme A Acyltransferase 2, Acyl-CoA Hydrolase, Mitochondrial, Acetyl-CoA Acetyltransferase, T1, Acetyl-CoA Acyltransferase, Beta Ketothiolase, Beta-Ketothiolase
    Associations

    News

    Trials
    3ms
    The metabolic crossroads: glycolysis in cancer and neurodegeneration. (PubMed, BMC Neurol)
    Our findings identify glycolysis as a shared but oppositely regulated pathway linking cancer and neurodegeneration. ACAA2 may serve as a molecular mediator of this metabolic divergence, offering new insights into disease crosstalk and potential therapeutic targets.
    Journal
    |
    ACAA2 (Acetyl-CoA Acyltransferase 2)
    almost2years
    The oncogenic role and regulatory mechanism of ACAA2 in human ovarian cancer. (PubMed, Mol Carcinog)
    ACAA2 regulated the malignant progression of ovarian cancer through the WNT/β-Catenin signaling pathway probably. ACAA2 is an oncogene in ovarian cancer and has the potential to be a target for ovarian cancer therapy.
    Journal
    |
    ACAA2 (Acetyl-CoA Acyltransferase 2)
    2years
    ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype. (PubMed, Br J Cancer)
    ACAA2 expression is elevated in aggressive SCNCs such as NEPC and SCLC, suggesting it is a potential molecular indicator for SCNCs.
    Journal
    |
    ACAA2 (Acetyl-CoA Acyltransferase 2)
    over2years
    Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive Microenvironment. (PubMed, J Hepatocell Carcinoma)
    In a conclusion, downregulated ACAA2 promoted the progression of hepatocellular carcinoma and might be participated in the formation of immunosuppressive microenvironment. ACAA2 could be served as a favorable indicator for the prognosis of HCC and an ideal biomarker for immunotherapy.
    Journal • IO biomarker
    |
    HLA-E (Major Histocompatibility Complex, Class I, E) • CXCL1 (Chemokine (C-X-C motif) ligand 1) • ACAA2 (Acetyl-CoA Acyltransferase 2)
    |
    FOXP3 expression